Abstract 2928: Evaluating Cks1-Skp2 interface as an effective therapeutic target forRB1-deficient metastatic castration-resistant prostate cancer (mCRPC)
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI